AU2002363386A1 - Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins - Google Patents
Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteinsInfo
- Publication number
- AU2002363386A1 AU2002363386A1 AU2002363386A AU2002363386A AU2002363386A1 AU 2002363386 A1 AU2002363386 A1 AU 2002363386A1 AU 2002363386 A AU2002363386 A AU 2002363386A AU 2002363386 A AU2002363386 A AU 2002363386A AU 2002363386 A1 AU2002363386 A1 AU 2002363386A1
- Authority
- AU
- Australia
- Prior art keywords
- medicaments
- prevention
- appearance
- preparation
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004965 antibodies Human genes 0.000 title 1
- 108090001123 antibodies Proteins 0.000 title 1
- 230000001363 autoimmune Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0113360A FR2830865B1 (en) | 2001-10-17 | 2001-10-17 | PEPTIDE LURES FOR THE PREPARATION OF MEDICINES FOR THE PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES, OR OF DISORDERS RELATED TO THE APPEARANCE OF ANTIBODIES DIRECTED AGAINST EXOGENOUS PROTEINS |
FR01/13360 | 2001-10-17 | ||
PCT/FR2002/003557 WO2003040176A2 (en) | 2001-10-17 | 2002-10-17 | Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002363386A1 true AU2002363386A1 (en) | 2003-07-24 |
AU2002363386B2 AU2002363386B2 (en) | 2009-01-08 |
Family
ID=8868379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002363386A Ceased AU2002363386B2 (en) | 2001-10-17 | 2002-10-17 | Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
Country Status (9)
Country | Link |
---|---|
US (1) | US7632817B2 (en) |
EP (1) | EP1438330B1 (en) |
JP (1) | JP2005515177A (en) |
AT (1) | ATE452139T1 (en) |
AU (1) | AU2002363386B2 (en) |
CA (1) | CA2463745A1 (en) |
DE (1) | DE60234786D1 (en) |
FR (1) | FR2830865B1 (en) |
WO (1) | WO2003040176A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110014226A1 (en) * | 2008-03-18 | 2011-01-20 | Caulfield Michael J | high throughput protein interaction assay |
TWI541020B (en) | 2008-04-17 | 2016-07-11 | 巴克斯歐塔公司 | Biologically active peptides |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2473388A (en) * | 1987-11-16 | 1989-06-22 | Scripps Clinic And Research Foundation | Treatment of factor viii inhibitors |
US5187155A (en) * | 1989-06-23 | 1993-02-16 | Board Of Regents, The University Of Texas System | Anticoagulant peptides |
US6180371B1 (en) * | 1996-06-26 | 2001-01-30 | Emory University | Modified factor VIII |
BE1008491A3 (en) * | 1994-07-14 | 1996-05-07 | Croix Rouge De Belgique Depart | Sequence factor viii polypeptide antigenic, fragments and / or epitopes thereof. |
US5846933A (en) * | 1996-06-28 | 1998-12-08 | Korngold; Robert | CD-4 derived peptides that inhibit immune responses |
GB9805913D0 (en) * | 1998-03-19 | 1998-05-13 | Kings College University Of Lo | Diagnosis of ms |
EP1005551A2 (en) * | 1997-01-31 | 2000-06-07 | Human Genome Sciences, Inc. | Tissue factor pathway inhibitor-3 |
US6043220A (en) * | 1997-12-03 | 2000-03-28 | Intrabiotics Pharmaceuticals, Inc. | Threonine-containing protegrins |
CA2315537A1 (en) * | 1997-12-16 | 1999-06-24 | Regents Of The University Of Minnesota | Methods to treat undesirable immune responses |
US6197526B1 (en) * | 1999-01-04 | 2001-03-06 | Dyax Corp. | Polypeptides for binding human factor VIII and fragments of human factor VIII |
-
2001
- 2001-10-17 FR FR0113360A patent/FR2830865B1/en not_active Expired - Fee Related
-
2002
- 2002-10-17 DE DE60234786T patent/DE60234786D1/en not_active Expired - Lifetime
- 2002-10-17 JP JP2003542221A patent/JP2005515177A/en active Pending
- 2002-10-17 AU AU2002363386A patent/AU2002363386B2/en not_active Ceased
- 2002-10-17 US US10/492,929 patent/US7632817B2/en not_active Expired - Fee Related
- 2002-10-17 AT AT02802664T patent/ATE452139T1/en not_active IP Right Cessation
- 2002-10-17 WO PCT/FR2002/003557 patent/WO2003040176A2/en active Application Filing
- 2002-10-17 CA CA002463745A patent/CA2463745A1/en not_active Abandoned
- 2002-10-17 EP EP02802664A patent/EP1438330B1/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2484399A (en) | Controlled release delivery of peptide or protein | |
EP1329458A3 (en) | Peptides that lower blood glucose levels | |
EP1536828A4 (en) | Methods of delivery of exogenous proteins to the cytosol and uses thereof | |
AU2003214230A8 (en) | High protein concentrate from corn and methods of preparation thereof | |
WO2002059143A3 (en) | Therapeutic peptides for demyelinating conditions | |
AU2003267532A1 (en) | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
WO2001014395A3 (en) | Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof | |
AU2002300166A1 (en) | Process for the Preparation of Peptides | |
AU2001249214A1 (en) | Suppression of vascular disorders by mucosal administration of heat shock protein peptides | |
GB0031489D0 (en) | Light delivery system for improving the appearance of skin | |
AU2002363386A1 (en) | Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins | |
AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
AU7508100A (en) | Human seizure related proteins | |
WO2003055440A8 (en) | Compositions and methods for the treatement of immune related diseases | |
AU2002342858A1 (en) | Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus | |
AU2003295435A1 (en) | Biological carriers for the delivery of proteins or peptides | |
AU2002364757A1 (en) | Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases | |
WO2003040176A3 (en) | Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins | |
AU2002308267A1 (en) | Regulation of human icos v protein | |
WO2001016319A3 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2002365148A1 (en) | Human ras interacting protein | |
AU2002215956A1 (en) | Regulation of human pgc-1-like protein | |
AU2002231620A1 (en) | Regulation of human patched-like protein | |
AU3902600A (en) | Compositions and methods for the treatment of immune related diseases |